Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anders Sundin

Showing results (81-90 of 198) with videos related to

Pageof 20
Sort By:
Cancers|March 6, 2021
Peptide Receptor Radionuclide Therapy (PRRT) with <sup>177</sup>Lu-DOTATATE; Differences in Tumor Dosimetry, Vascularity and Lesion Metrics in Pancreatic and Small Intestinal Neuroendocrine NeoplasmsUlrika Jahn, Ezgi Ilan, Mattias Sandström, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 20, 2009
[Positron emission tomography in neuroendocrine tumours]Martin Biermann, Boel Johnsen, Halfdan Sørbye, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 7, 2007
Biodistribution of 211At-labeled humanized monoclonal antibody A33Ylva Almqvist, Ann-Charlott Steffen, Hans Lundqvist, et al.
Acta Oncologica (Stockholm, Sweden)|September 19, 2017
Kidney dosimetry during <sup>177</sup>Lu-DOTATATE therapy in patients with neuroendocrine tumors: aspects on calculation and toleranceMattias Sandström, Ulrike Garske-Román, Silvia Johansson, et al.
Acta Radiologica Open|December 1, 2016
Preoperative MR staging of cervical carcinoma: are oblique and contrast-enhanced sequences necessary?Susanne Fridsten, Ann-Cathrin Hellström, Kristina Hellman, et al.
EJNMMI Research|November 25, 2021
Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by <sup>68</sup>Ga-DOTATOC PET/CTUlrika Jahn, Ezgi Ilan, Irina Velikyan, et al.
Bioorganic & Medicinal Chemistry|November 16, 2024
Sulfonamide-derivatized galactosides selectively target an unexplored binding site in the galectin-9N-terminal domainMukul Mahanti, Sofi Gummesson, Anders Sundin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 7, 2021
A Clinical Challenge: Endocrine and Imaging Investigations of Adrenal MassesAnders Sundin, Elif Hindié, Anca M Avram, et al.
Cancers|November 12, 2013
PET-Guided Surgery - High Correlation between Positron Emission Tomography with 11C-5-Hydroxytryptophane (5-HTP) and Surgical Findings in Abdominal Neuroendocrine TumoursHåkan Orlefors, Anders Sundin, Barbro Eriksson, et al.
Nuclear Medicine and Biology|December 6, 2011
Preclinical evaluation of a 68Ga-labeled biotin analogue for applications in islet transplantationOlof Eriksson, Fredrik Carlsson, Elisabeth Blom, et al.
Pageof 20

Showing results (81-90 of 198) with videos related to

Sort By:
Pageof 20
Cancers|March 6, 2021
Peptide Receptor Radionuclide Therapy (PRRT) with <sup>177</sup>Lu-DOTATATE; Differences in Tumor Dosimetry, Vascularity and Lesion Metrics in Pancreatic and Small Intestinal Neuroendocrine NeoplasmsUlrika Jahn, Ezgi Ilan, Mattias Sandström, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|August 20, 2009
[Positron emission tomography in neuroendocrine tumours]Martin Biermann, Boel Johnsen, Halfdan Sørbye, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 7, 2007
Biodistribution of 211At-labeled humanized monoclonal antibody A33Ylva Almqvist, Ann-Charlott Steffen, Hans Lundqvist, et al.
Acta Oncologica (Stockholm, Sweden)|September 19, 2017
Kidney dosimetry during <sup>177</sup>Lu-DOTATATE therapy in patients with neuroendocrine tumors: aspects on calculation and toleranceMattias Sandström, Ulrike Garske-Román, Silvia Johansson, et al.
Acta Radiologica Open|December 1, 2016
Preoperative MR staging of cervical carcinoma: are oblique and contrast-enhanced sequences necessary?Susanne Fridsten, Ann-Cathrin Hellström, Kristina Hellman, et al.
EJNMMI Research|November 25, 2021
Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by <sup>68</sup>Ga-DOTATOC PET/CTUlrika Jahn, Ezgi Ilan, Irina Velikyan, et al.
Bioorganic & Medicinal Chemistry|November 16, 2024
Sulfonamide-derivatized galactosides selectively target an unexplored binding site in the galectin-9N-terminal domainMukul Mahanti, Sofi Gummesson, Anders Sundin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 7, 2021
A Clinical Challenge: Endocrine and Imaging Investigations of Adrenal MassesAnders Sundin, Elif Hindié, Anca M Avram, et al.
Cancers|November 12, 2013
PET-Guided Surgery - High Correlation between Positron Emission Tomography with 11C-5-Hydroxytryptophane (5-HTP) and Surgical Findings in Abdominal Neuroendocrine TumoursHåkan Orlefors, Anders Sundin, Barbro Eriksson, et al.
Nuclear Medicine and Biology|December 6, 2011
Preclinical evaluation of a 68Ga-labeled biotin analogue for applications in islet transplantationOlof Eriksson, Fredrik Carlsson, Elisabeth Blom, et al.
Pageof 20